Show
Sort by
-
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
-
- Journal Article
- A1
- open access
Selinexor, bortezomib and dexamethasone : an effective salvage regimen for heavily pretreated myeloma patients
-
CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment
(2022) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 197(supplement 1). p.118-119 -
Immunomodulators in newly diagnosed multiple myeloma : current and future concepts
-
Compass : a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients
(2021) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. In Clinical Lymphoma Myeloma & Leukemia 21(Supplement 2). p.S124-S124 -
- Journal Article
- A1
- open access
Quality of life analyses in patients with multiple myeloma : results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study
-
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA) : an open-label, randomised, phase 3 trial
-
Oral selinexor-dexamethasone for triple-class refractory multiple myeloma
-
Darbepoetin alfa for the treatment of anemic patients with myelodysplastic syndrome : a Belgian single-arm, companion trial to the Arcade phase 3 study
-
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone
-
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
-
Neutrophil extracellular trap cell death requires both autophagy and superoxide generation
-
- Journal Article
- A1
- open access
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study